ABT-806i
- Generic Name
- ABT-806i
An Evaluation of the Biodistribution and Imaging Characteristics of ABT-806i (111In-ABT-806) in Subjects With Advanced Solid Tumor Types
- First Posted Date
- 2011-11-16
- Last Posted Date
- 2013-01-14
- Lead Sponsor
- AbbVie (prior sponsor, Abbott)
- Target Recruit Count
- 18
- Registration Number
- NCT01472003
- Locations
- 🇦🇺
Site Reference ID/Investigator# 52203, Heidelberg, Australia
🇦🇺Site Reference ID/Investigator# 58242, Herston, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath